When doctors told Australian Greg Jefferys he had hepatitis C and the disease was destroying his liver, the devastating diagnosis was compounded by the cost of a cure.
Unable to afford Sovaldi, hailed as a miracle drug, the 61-year-old flew to India, one of a growing army of patients seeking out low-cost, life-saving medicines on the subcontinent.
Their illnesses vary — hepatitis C, cancer and HIV are among the most common — but they are almost always desperate, seeing in India their only hope to save their life or that of a loved one.
Photo: AFP
They contact underground “buyers clubs,” make the trip to India to buy from a legitimate distributor or seek out shady online pharmacies promising mail-order cures.
“The doctors told me ‘you’ve got Hepatitis C, you’ve probably got liver cancer,’” said Jefferys, a PhD student.
“The chatter was around the new generic versions of Sovaldi being released in India. I hopped on a plane to Chennai and in about two days I had an appointment with a specialist,” he said.
India earned a nickname as “the pharmacy to the developing world” for its tough stance on patents.
Successive governments have taken a view that patents should be granted only for major innovations, not updates to existing compounds — allowing domestic manufacturers to make generic versions of drugs at vastly lower cost.
Sovaldi, chemically known as sofosbuvir, is made by US pharmaceutical giant Gilead and costs US$84,000 for a 12-week cycle of treatment in the US.
Rejected for a patent in India, generic drug makers, some licensed by Gilead, produce versions such as Mylan’s MyHep, that cost less than US$900 a cycle.
“This is something I observe more and more,” said Leena Menghaney, who runs Medecins Sans Frontieres’ Access Campaign in India, which works to broaden access to drugs.
“All kinds of people and patients across the world are starting to access medicines from India. They travel themselves, or they contact a friend,” she said.
More than 130 million people live with chronic hepatitis C worldwide, according to the WHO, and 500,000 die each year from related liver diseases.
Since writing a blog, Jefferys receives 150 e-mails a day from people in the US, Britain and elsewhere asking for help.
When Loon Gangte, a Delhi-based HIV activist, was diagnosed with the virus in 1997, the price of treatment was far beyond his reach.
However, the advent of generic Indian anti-retrovirals saved his life — and made the country a global center for cheap, lifesaving HIV drugs.
Gangte is open about carrying medicines overseas for others and says in a decade he has been stopped just once, at Thai customs, and fined.
Most countries allow patients to import small amounts of medicines only for personal use.
Campaigning by activists like Gangte for better access to HIV treatments helped give rise to so-called buyers clubs, made famous by the 2013 Hollywood film.
“When I saw Dallas Buyers Club, I laughed,” said a woman who asked to be called Meera,who helps one Delhi club by ferrying drugs illegally in her suitcase whenever she travels. “I hate the term ‘drug tourism.’ This is about saving lives.”
Dinesh (not his real name), a long-time HIV campaigner, began working full-time for the same buyers club in August last year, helping people obtain medicines for a nominal fee.
He is not sure how people find him — he has no online presence — but gets requests from as far afield as Austria and Indonesia.
“My family were a bit reluctant, there is always a grey area in this, but I fear only the one above. I feel completely that this is right,” he said.
Pharmaceutical firms say India’s disregard for patents will stifle innovation or make drugs commercially unfeasible — Gilead paid US$11 billion to buy the developer of Sovaldi in 2012.
However, after losing several high-profile patent battles, it appears drugmakers can do little to combat the Indian government’s will or that of overseas patients determined to import drugs.
Gilead spokesman Nick Francis said the company was “aware such activity may occur.”
Perhaps the riskiest route is online pharmacies — a search on e-marketplace IndiaMart turns up dozens claiming to sell generics — with no guarantee against counterfeits.
However, legal channels are springing up, including Delhi-based Ikris Pharma Network, set up in August 2014, which does not sell drugs, but connects patients to genuine distributors.
Founder Praveen Sikri receives 70 calls a day from people struggling to access drugs, including generic Veenat, for cancer.
“Either the drug is not available or it is very expensive,” Sikri said. “We help the patient to get the product in a legalized manner.”
One recent e-mail is from a young man in San Francisco whose grandad desperately needs medicine for a stomach tumor.
In India, one way or another, he will probably be able to find it.
“There are many, many people doing this,” Sikri said.
Stephen Garrett, a 27-year-old graduate student, always thought he would study in China, but first the country’s restrictive COVID-19 policies made it nearly impossible and now he has other concerns. The cost is one deterrent, but Garrett is more worried about restrictions on academic freedom and the personal risk of being stranded in China. He is not alone. Only about 700 American students are studying at Chinese universities, down from a peak of nearly 25,000 a decade ago, while there are nearly 300,000 Chinese students at US schools. Some young Americans are discouraged from investing their time in China by what they see
MAJOR DROP: CEO Tim Cook, who is visiting Hanoi, pledged the firm was committed to Vietnam after its smartphone shipments declined 9.6% annually in the first quarter Apple Inc yesterday said it would increase spending on suppliers in Vietnam, a key production hub, as CEO Tim Cook arrived in the country for a two-day visit. The iPhone maker announced the news in a statement on its Web site, but gave no details of how much it would spend or where the money would go. Cook is expected to meet programmers, content creators and students during his visit, online newspaper VnExpress reported. The visit comes as US President Joe Biden’s administration seeks to ramp up Vietnam’s role in the global tech supply chain to reduce the US’ dependence on China. Images on
Taiwan Transport and Storage Corp (TTS, 台灣通運倉儲) yesterday unveiled its first electric tractor unit — manufactured by Volvo Trucks — in a ceremony in Taipei, and said the unit would soon be used to transport cement produced by Taiwan Cement Corp (TCC, 台灣水泥). Both TTS and TCC belong to TCC International Holdings Ltd (台泥國際集團). With the electric tractor unit, the Taipei-based cement firm would become the first in Taiwan to use electric vehicles to transport construction materials. TTS chairman Koo Kung-yi (辜公怡), Volvo Trucks vice president of sales and marketing Johan Selven, TCC president Roman Cheng (程耀輝) and Taikoo Motors Group
New apartments in Taiwan’s major cities are getting smaller, while old apartments are increasingly occupied by older people, many of whom live alone, government data showed. The phenomenon has to do with sharpening unaffordable property prices and an aging population, property brokers said. Apartments with one bedroom that are two years old or older have gained a noticeable presence in the nation’s six special municipalities as well as Hsinchu county and city in the past five years, Evertrust Rehouse Co (永慶房產集團) found, citing data from the government’s real-price transaction platform. In Taipei, apartments with one bedroom accounted for 19 percent of deals last